BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26175184)

  • 1. Structural and functional characteristics of virgin and fouled Protein A MabSelect resin cycled in a monoclonal antibody purification process.
    Zhang S; Xu K; Daniels W; Salm J; Glynn J; Martin J; Gallo C; Godavarti R; Carta G
    Biotechnol Bioeng; 2016 Feb; 113(2):367-75. PubMed ID: 26175184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature of foulants and fouling mechanism in the Protein A MabSelect resin cycled in a monoclonal antibody purification process.
    Zhang S; Daniels W; Salm J; Glynn J; Martin J; Gallo C; Godavarti R; Carta G
    Biotechnol Bioeng; 2016 Jan; 113(1):141-9. PubMed ID: 26184599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic understanding of fouling of protein A chromatography resin.
    Pathak M; Rathore AS
    J Chromatogr A; 2016 Aug; 1459():78-88. PubMed ID: 27423774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and protein adsorption mechanisms of clean and fouled tentacle-type anion exchangers used in a monoclonal antibody polishing step.
    Corbett R; Carta G; Iskra T; Gallo C; Godavarti R; Salm JR
    J Chromatogr A; 2013 Feb; 1278():116-25. PubMed ID: 23347978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fouling of an anion exchange chromatography operation in a monoclonal antibody process: Visualization and kinetic studies.
    Close EJ; Salm JR; Iskra T; Sørensen E; Bracewell DG
    Biotechnol Bioeng; 2013 Sep; 110(9):2425-35. PubMed ID: 23483524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process development in the Quality by Design paradigm: Modeling of Protein A chromatography resin fouling.
    Shekhawat LK; Pathak M; Sakar J; Rathore AS
    J Chromatogr A; 2018 Oct; 1570():56-66. PubMed ID: 30076007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A safe, effective, and facility compatible cleaning in place procedure for affinity resin in large-scale monoclonal antibody purification.
    Wang L; Dembecki J; Jaffe NE; O'Mara BW; Cai H; Sparks CN; Zhang J; Laino SG; Russell RJ; Wang M
    J Chromatogr A; 2013 Sep; 1308():86-95. PubMed ID: 23953712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing the functional lifetime of Protein A resins.
    Zhang J; Siva S; Caple R; Ghose S; Gronke R
    Biotechnol Prog; 2017 May; 33(3):708-715. PubMed ID: 28218470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-column ATR-FTIR spectroscopy to monitor affinity chromatography purification of monoclonal antibodies.
    Boulet-Audet M; Kazarian SG; Byrne B
    Sci Rep; 2016 Jul; 6():30526. PubMed ID: 27470880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving affinity chromatography resin efficiency using semi-continuous chromatography.
    Mahajan E; George A; Wolk B
    J Chromatogr A; 2012 Mar; 1227():154-62. PubMed ID: 22265178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of protein A chromatographic stationary phases: performance characteristics for monoclonal antibody purification.
    Liu Z; Mostafa SS; Shukla AA
    Biotechnol Appl Biochem; 2015; 62(1):37-47. PubMed ID: 24823474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical modification of protein A chromatography ligands with polyethylene glycol. I: Effects on IgG adsorption equilibrium, kinetics, and transport.
    Weinberg J; Zhang S; Crews G; Carta G; Przybycien T
    J Chromatogr A; 2018 Apr; 1546():77-88. PubMed ID: 29551236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recent Protein A stationary phase innovations for capture of biotherapeutics.
    Pabst TM; Thai J; Hunter AK
    J Chromatogr A; 2018 Jun; 1554():45-60. PubMed ID: 29685337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein a resin lifetime study: Evaluation of protein a resin performance with a model-based approach in continuous capture.
    Behere K; Cha B; Yoon S
    Prep Biochem Biotechnol; 2018 Mar; 48(3):242-256. PubMed ID: 29355458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals.
    Ishihara T; Nakajima N; Kadoya T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2141-4. PubMed ID: 20591751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of the rodent retrovirus, XMuLV, by protein A chromatography.
    Bach J; Connell-Crowley L
    Biotechnol Bioeng; 2015 Apr; 112(4):743-50. PubMed ID: 25335906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanistic study of Protein A chromatography resin lifetime.
    Jiang C; Liu J; Rubacha M; Shukla AA
    J Chromatogr A; 2009 Jul; 1216(31):5849-55. PubMed ID: 19539295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enhanced regeneration strategy to improve microbial control and prolong resin lifetime for Protein A resin in large-scale monoclonal antibody (mAb) purification.
    Zhou T; Wang L; Zhang Z; Jin M
    J Biotechnol; 2019 Jan; 289():118-125. PubMed ID: 30502366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfolding and aggregation of a glycosylated monoclonal antibody on a cation exchange column. Part I. Chromatographic elution and batch adsorption behavior.
    Guo J; Zhang S; Carta G
    J Chromatogr A; 2014 Aug; 1356():117-28. PubMed ID: 25015241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of using continuous chromatography in downstream processing: Comparison of costs and product quality for a hybrid process vs. a conventional batch process.
    Ötes O; Flato H; Winderl J; Hubbuch J; Capito F
    J Biotechnol; 2017 Oct; 259():213-220. PubMed ID: 28684321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.